A randomized controlled trial (RCT) for treatment-resistant depression did not show any beneficial effect overall, although patients with high C-reactive protein (CRP) at baseline appeared to have greater improvement in depression scores [145]. The gene discussed is CRP; the disease is depressive symptom measurement.